760 related articles for article (PubMed ID: 34039287)
1. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
[TBL] [Abstract][Full Text] [Related]
8. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.
Rashid-Abdi M; Krifors A; Sälléber A; Eriksson J; Månsson E
Infect Dis (Lond); 2021 Mar; 53(3):169-175. PubMed ID: 33232190
[No Abstract] [Full Text] [Related]
9. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy.
Scozzari G; Costa C; Migliore E; Coggiola M; Ciccone G; Savio L; Scarmozzino A; Pira E; Cassoni P; Galassi C; Cavallo R; The Collaborative Group
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205134
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.
Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG
Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092
[TBL] [Abstract][Full Text] [Related]
12. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.
Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B
West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M
Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
19. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study of SARS-CoV-2 antibodies among healthcare workers in a tertiary care hospital in Taiwan: implications for protection against the Omicron variants.
Chen CH; Chao DY; Kor CT; Kuo SF; Lin JS; Lai HW; Liu YT; Lin CH; Chen MK
BMC Infect Dis; 2024 May; 24(1):529. PubMed ID: 38802771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]